Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
A hallmark of human cancer is global DNA hypomethylation (GDHO), but the mechanisms accounting for this defect and its pathological consequences have not been investigated in human epithelial ovarian cancer (EOC). In EOC, GDHO was associated with advanced disease and reduced overall and disease-free survival. GDHO (+) EOC tumors displayed a proliferative gene expression signature, including FOXM1 and CCNE1 overexpression. Furthermore, DNA hypomethylation in these tumors was enriched within genomic blocks (hypomethylated blocks) that overlapped late-replicating regions, lamina-associated domains, PRC2 binding sites, and the H3K27me3 histone mark. Increased proliferation coupled with hypomethylated blocks at late-replicating regions suggests a passive hypomethylation mechanism. This hypothesis was further supported by our observation that cytosine DNA methyltransferases (DNMTs) and UHRF1 showed significantly reduced expression in GDHO (+) EOC after normalization to canonical proliferation markers, including MKI67. Finally, GDHO (+) EOC tumors had elevated chromosomal instability (CIN), and copy number alterations (CNA) were enriched at the DNA hypomethylated blocks. Together, these findings implicate a passive DNA demethylation mechanism in ovarian cancer that is associated with genomic instability and poor prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
Circos: An information aesthetic for comparative genomics
Krzywinski, M., Schein, J., Birol, İ., Connors, J., Gascoyne, R., Horsman, D., Jones, S. J., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 10,964
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
Krueger, F., & Andrews, S. R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr167 · Cited by 5,297
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
BEDTools: The Swiss‐Army Tool for Genome Feature Analysis
Quinlan, A. R. (2014) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1112s47 · Cited by 2,370
The history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
[9] TM4 Microarray Software Suite
Saeed, A. I., Bhagabati, N. K., Braisted, J. C., Liang, W., Sharov, V., Howe, E. A., Li, J., Thiagarajan, M., White, J. A., & Quackenbush, J. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)11009-5 · Cited by 1,983
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499
Rethinking ovarian cancer: recommendations for improving outcomes
Vaughan, S., Coward, J. I., Bast, R. C., Berchuck, A., Berek, J. S., Brenton, J. D., Coukos, G., Crum, C. C., Drapkin, R., Etemadmoghadam, D., et al. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3144 · Cited by 1,464
UHRF1 Plays a Role in Maintaining DNA Methylation in Mammalian Cells
Bostick, M., Kim, J. K., Estève, P.-O., Clark, A., Pradhan, S., & Jacobsen, S. E. (2007) · Science · doi:10.1126/science.1147939 · Cited by 1,455
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
Emerging landscape of oncogenic signatures across human cancers
Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013) · Nature Genetics · doi:10.1038/ng.2762 · Cited by 1,378
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N., & Szallasi, Z. (2006) · Nature Genetics · doi:10.1038/ng1861 · Cited by 1,193
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143 · cited 1×
“frequently at genomic regions occupied by polycomb group proteins in embryonic stem cells [1,3].”
BackgroundTumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
Increased methylation variation in epigenetic domains across cancer types
Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Langmead, B., McDonald, O. G., Wen, B., Wu, H., Liu, Y., Diep, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.865 · Cited by 1,045
Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome
Sandoval, J., Heyn, H., Moran, S., Serra-Musach, J., Pujana, M. A., Bibikova, M., & Esteller, M. (2011) · Epigenetics · doi:10.4161/epi.6.6.16196 · Cited by 990 · cited 4×
“As methylation at different genomic locations has distinct consequences, we calculated differentially methylated CpG sites (DMC) independently for genes, CpG islands, CpG shores, CpG shelves, and CpG open seas, as described previously [58].”
BackgroundMethodInfluentialThe 5-methylcytosine content of DNA from human tumors
Gama-Sosa, M. A., Slagel, V. A., Trewyn, R. W., Oxenhandler, R., Kuo, K. C., Gehrke, C. W., & Ehrlich, M. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.19.6883 · Cited by 844
Berman, B. P., Weisenberger, D. J., Aman, J. F., Hinoue, T., Ramjan, Z., Liu, Y., Noushmehr, H., Lange, C. P. E., van Dijk, C. M., Tollenaar, R. A. E. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.969 · Cited by 660
Common markers of proliferation
Whitfield, M. L., George, L. K., Grant, G. D., & Perou, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1802 · Cited by 650 · cited 4×
“Normalization Cancers 2020, 12, 764 12 of 25 of DNMTs and UHRF1 to other markers of cancer cell proliferation, including PLK1 and BUB1 [44], provided similar results as seen with MKI67 normalization (Figure S11 and Figure S12).”
ResultInfluentialLINE-1 elements in structural variation and disease
Beck, C. R., Garcia-Perez, J. L., Badge, R. M., & Moran, J. V. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082509-141802 · Cited by 615 · cited 1×
“In agreement, DNA hypomethylation occurs at repetitive elements (RE), including the interspersed retrotransposon LINE-1 [7], which accounts for ~17% of the genome.”
BackgroundWen, B., Wu, H., Shinkai, Y., Irizarry, R. A., & Feinberg, A. P. (2009) · Nature Genetics · doi:10.1038/ng.297 · Cited by 614
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Hinoue, T., Weisenberger, D. J., Lange, C. P. E., Shen, H., Byun, H.-M., Van Den Berg, D., Malik, S., Pan, F., Noushmehr, H., van Dijk, C. M., et al. (2012) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 601
Comprehensive analysis of DNA methylation data with RnBeads
Assenov, Y., Müller, F., Lutsik, P., Walter, J., Lengauer, T., & Bock, C. (2014) · Nature Methods · doi:10.1038/nmeth.3115 · Cited by 598
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
Timp, W., & Feinberg, A. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3486 · Cited by 586
Hon, G. C., Hawkins, R. D., Caballero, O. L., Lo, C., Lister, R., Pelizzola, M., Valsesia, A., Ye, Z., Kuan, S., Edsall, L. E., et al. (2012) · Genome Research · doi:10.1101/gr.125872.111 · Cited by 583 · cited 2×
“Hypomethylated blocks overlap lamina-associated domains (LADs) and, interestingly, can contain epigenetically silenced genes, as well as genomic regions showing high gene expression variability [15,17,18].”
BackgroundThe activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., & Boon, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7149 · Cited by 542
Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers
Ting, D. T., Lipson, D., Paul, S., Brannigan, B. W., Akhavanfard, S., Coffman, E. J., Contino, G., Deshpande, V., Iafrate, A. J., Letovsky, S., et al. (2011) · Science · doi:10.1126/science.1200801 · Cited by 540
Reduced genomic 5-methylcytosine content in human colonic neoplasia.
Feinberg, A. P., Gehrke, C. W., Kuo, K. C., & Ehrlich, M. (1988) · PubMed · Cited by 484
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
Almeida, L. G., Sakabe, N. J., deOliveira, A. R., Silva, M. C. C., Mundstein, A. S., Cohen, T., Chen, Y.-T., Chua, R., Gurung, S., Gnjatic, S., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn673 · Cited by 433
The Human Tumor Antigen PRAME Is a Dominant Repressor of Retinoic Acid Receptor Signaling
Epping, M. T., Wang, L., Edel, M. J., Carlée, L., Hernandez, M., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.07.003 · Cited by 432
DNA methylation loss in late-replicating domains is linked to mitotic cell division
Zhou, W., Dinh, H. Q., Ramjan, Z., Weisenberger, D. J., Nicolet, C. M., Shen, H., Laird, P. W., & Berman, B. P. (2018) · Nature Genetics · doi:10.1038/s41588-018-0073-4 · Cited by 405 · cited 4×
“Finally, a recent landmark study demonstrated that DNA hypomethylation in cancer is concentrated at late-replicating domains partially methylated in normal tissues, and are enriched in solo “WCGW” CpG sites [28].”
BackgroundResultInfluentialPan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
Saghafinia, S., Mina, M., Riggi, N., Hanahan, D., & Ciriello, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.082 · Cited by 357
Rodriguez, J., Frigola, J., Vendrell, E., Risques, R.-A., Fraga, M. F., Morales, C., Moreno, V., Esteller, M., Capellà, G., Ribas, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0293 · Cited by 335
UHRF1 Overexpression Drives DNA Hypomethylation and Hepatocellular Carcinoma
Mudbhary, R., Hoshida, Y., Chernyavskaya, Y., Jacob, V., Villanueva, A., Fiel, M. I., Chen, X., Kojima, K., Thung, S., Bronson, R. T., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.003 · Cited by 309
Replication timing-related and gene body-specific methylation of active human genes
Aran, D., Toperoff, G., Rosenberg, M., & Hellman, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq513 · Cited by 304
Daskalos, A., Nikolaidis, G., Xinarianos, G., Savvari, P., Cassidy, A., Zakopoulou, R., Kotsinas, A., Gorgoulis, V., Field, J. K., & Liloglou, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.23849 · Cited by 290
Karpf, A. R., & Matsui, S.-I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1961 · Cited by 276
Self-citationGlobal DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage
Suzuki, K., Suzuki, I., Leodolter, A., Alonso, S., Horiuchi, S., Yamashita, K., & Perucho, M. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.016 · Cited by 269
Reactivating the expression of methylation silenced genes in human cancer
Karpf, A. R., & Jones, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205602 · Cited by 264
Self-citationDNA Hypomethylation and Ovarian Cancer Biology
Widschwendter, M., Jiang, G., Woods, C., Müller, H. M., Fiegl, H., Goebel, G., Marth, C., Müller-Holzner, E., Zeimet, A. G., Laird, P. W., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0238 · Cited by 254
Cadieux, B., Ching, T.-T., VandenBerg, S. R., & Costello, J. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1547 · Cited by 234
Methylation of Endogenous Human Retroelements in Health and Disease
Schulz, W. A., Steinhoff, C., & Florl, A. R. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-31181-5_11 · Cited by 222
Hypomethylation of DNA in pathological conditions of the human prostate.
Bedford, M. T., & van Helden, P. D. (1987) · PubMed · Cited by 219
Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer
Barger, C. J., Branick, C., Chee, L., & Karpf, A. R. (2019) · Cancers · doi:10.3390/cancers11020251 · Cited by 209
Self-citationLarge hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors
Timp, W., Bravo, H., McDonald, O. G., Goggins, M., Umbricht, C., Zeiger, M., Feinberg, A. P., & Irizarry, R. A. (2014) · Genome Medicine · doi:10.1186/preaccept-1714377612132518 · Cited by 204
Robertson, K. D. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.10.2108 · Cited by 199
Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
Odunsi, K., Matsuzaki, J., James, S. R., Mhawech-Fauceglia, P., Tsuji, T., Miller, A., Zhang, W., Akers, S. N., Griffiths, E. A., Miliotto, A., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0126 · Cited by 193
Self-citationSelective Anchoring of DNA Methyltransferases 3A and 3B to Nucleosomes Containing Methylated DNA
Jeong, S., Liang, G., Sharma, S., Lin, J. C., Choi, S. H., Han, H., Yoo, C. B., Egger, G., Yang, A. S., & Jones, P. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00484-09 · Cited by 192
Exploring Massive, Genome Scale Datasets with the GenometriCorr Package
Favorov, A., Mularoni, L., Cope, L. M., Medvedeva, Y., Mironov, A. A., Makeev, V. J., & Wheelan, S. J. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002529 · Cited by 183
Hayashi, A., Horiuchi, A., Kikuchi, N., Hayashi, T., Fuseya, C., 鈴木, 昭., Konishi, I., & Shiozawa, T. (2010) · International Journal of Cancer · doi:10.1002/ijc.25151 · Cited by 174
RNA sequencing of cancer reveals novel splicing alterations
Eswaran, J., Horvath, A., Godbole, S., Reddy, S. D., Mudvari, P., Ohshiro, K., Cyanam, D., Nair, S., Fuqua, S. A. W., Polyak, K., et al. (2013) · Scientific Reports · doi:10.1038/srep01689 · Cited by 170
Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells
Shipony, Z., Mukamel, Z., Cohen, N. M., Landan, G., Chomsky, E., Zeliger, S. R., Fried, Y. C., Ainbinder, E., Friedman, N., & Tanay, A. (2014) · Nature · doi:10.1038/nature13458 · Cited by 159 · cited 1×
“In this context, one report observed a link between DNA hypomethylation and late replication timing, and showed that the association of each of these sequences with LADs was secondary [71].”
BackgroundHua, K.-T., Wang, M.-Y., Chen, M.-W., Wei, L.-H., Chen, C.-K., Ko, C.-H., Jeng, Y.-M., Sung, P.-L., Jan, Y.-H., Hsiao, M., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-189 · Cited by 158
Oricchio, E., Sciamanna, I., Beraldi, R., Tolstonog, G. V., Schumann, G. G., & Spadafora, C. (2007) · Oncogene · doi:10.1038/sj.onc.1210214 · Cited by 146
The role of 5-hydroxymethylcytosine in human cancer
Pfeifer, G. P., Xiong, W., Hahn, M. A., & Jin, S. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1896-7 · Cited by 144
Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b
James, S. R., Link, P. A., & Karpf, A. R. (2006) · Oncogene · doi:10.1038/sj.onc.1209678 · Cited by 131
Self-citationJimeno, A., Li, J., Messersmith, W. A., Laheru, D. A., Rudek, M. A., Maniar, M. L., Hidalgo, M. M., Baker, S. D., & Donehower, R. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9788 · Cited by 128
Yang, G. S., Chang, B., Yang, F., Guo, X. Q., Cai, K. Q., Xiao, X., Wang, H., Sen, S., Hung, M., Mills, G. B., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3171 · Cited by 128
Karpf, A. R., Bai, S., James, S. R., Mohler, J. L., & Wilson, E. M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0400 · Cited by 126
Self-citationRegulation of Cancer Germline Antigen Gene Expression: Implications for Cancer Immunotherapy
Akers, S. N., Odunsi, K. O., & Karpf, A. R. (2010) · Future Oncology · doi:10.2217/fon.10.36 · Cited by 114
Self-citationDu, Q., Bert, S. A., Armstrong, N. J., Caldon, C. E., Song, J. Z., Nair, S. S., Gould, C. M., Luu, P., Peters, T. J., Khoury, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08302-1 · Cited by 114
Genome-wide hypomethylation in cancer may be a passive consequence of transformation
Wild, L., & Flanagan, J. M. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.03.003 · Cited by 113
Woloszynska-Read, A., Mhawech-Fauceglia, P., Yu, J., Odunsi, K., & Karpf, A. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5279 · Cited by 110
Self-citationKarpf, A. R. (2006) · Epigenetics · doi:10.4161/epi.1.3.2988 · Cited by 99
Self-citationEpigenetic loss of the PIWI/piRNA machinery in human testicular tumorigenesis
Ferreira, H. J., Heyn, H., del Muro, X. G., Vidal, A., Larriba, S., Muñoz, C., Villanueva, A., & Esteller, M. (2013) · Epigenetics · doi:10.4161/epi.27237 · Cited by 97
Wrzeszczyński, K. O., Varadan, V., Byrnes, J., Lum, E., Kamalakaran, S., Levine, D. A., Dimitrova, N., Zhang, M. Q., & Lucito, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028503 · Cited by 96
Teh, M., Gemenetzidis, E., PATEL, D., Tariq, R., Nadir, A., Bahta, A. W., Waseem, A., & Hutchison, I. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034329 · Cited by 92
PRAME expression and promoter hypomethylation in epithelial ovarian cancer
Zhang, W., Barger, C. J., Eng, K. H., Klinkebiel, D. L., Link, P. A., Omilian, A. R., Bshara, W., Odunsi, K. O., & Karpf, A. R. (2016) · Oncotarget · doi:10.18632/oncotarget.9977 · Cited by 91
Self-citationWoloszynska‐Read, A., Zhang, W., Yu, J., Link, P. A., Mhawech-Fauceglia, P. Y., Collamat, G., Akers, S. N., Ostler, K. R., Godley, L. A., Odunsi, K. O., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2315 · Cited by 90
Self-citationBarger, C. J., Zhang, W., Hillman, J. C., Stablewski, A. B., Higgins, M. J., Vanderhyden, B. C., Odunsi, K. O., & Karpf, A. R. (2015) · Oncotarget · doi:10.18632/oncotarget.4546 · Cited by 82
Self-citationZhang, W., Barger, C. J., Link, P. A., Mhawech-Fauceglia, P. Y., Miller, A., Akers, S. N., Odunsi, K. O., & Karpf, A. R. (2015) · Epigenetics · doi:10.1080/15592294.2015.1062206 · Cited by 71
Self-citationLiao, Y.-P., Chen, L.-Y., Huang, R., Su, P., Chan, M. W. Y., Chang, C., Yu, M., Wang, P., Yen, M.-S., Nephew, K. P., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt583 · Cited by 71
Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencing
Lee, E. J., Pei, L., Srivastava, G. P., Joshi, T., Kushwaha, G., Choi, J.-H., Robertson, K. D., Wang, X., Colbourne, J. K., Zhang, L., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr598 · Cited by 65
Combined analysis of DNA methylation and cell cycle in cancer cells
Desjobert, C., Maï, M. E., Gérard-Hirne, T., Guianvarc’h, D., Carrier, A., Pottier, C., Arimondo, P. B., & Riond, J. (2015) · Epigenetics · doi:10.1080/15592294.2014.995542 · Cited by 58
Pisanic, T. R., Asaka, S., Lin, S., Yen, T., Sun, H., Bahadirli-Talbott, A., Wang, T., Burns, K. H., Wang, T., & Shih, I. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.11.005 · Cited by 57
Akers, S. N., Moysich, K. B., Zhang, W., Lai, G. C., Miller, A., Lele, S., Odunsi, K. O., & Karpf, A. R. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.12.024 · Cited by 51
Self-citationTumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis
Peters, S. L., Hlady, R. A., Opavska, J., Klinkebiel, D. L., Pirruccello, S. J., Talmon, G. A., Sharp, J. G., Wu, L., Jaenisch, R., Simpson, M. A., et al. (2013) · Leukemia · doi:10.1038/leu.2013.364 · Cited by 45
Self-citationOpposing Roles of Dnmt1 in Early- and Late-Stage Murine Prostate Cancer
Kinney, S. R. M., Moser, M. T., Pascual, M., Greally, J. M., Foster, B. A., & Karpf, A. R. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00235-10 · Cited by 41
Self-citationHillman, J. C., Pugacheva, E. M., Barger, C. J., Sribenja, S., Rosario, S. R., Albahrani, M., Truskinovsky, A. M., Stablewski, A. B., Liu, S., Loukinov, D. I., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0310 · Cited by 40
Self-citationTang, M. E., Varadan, V., Kamalakaran, S., Zhang, M. Q., Dimitrova, N., & Hicks, J. B. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00197 · Cited by 38
Woloszynska‐Read, A., James, S. R., Song, C., et al. (2010) · PubMed · Cited by 27
Epigenetic activation of POTE genes in ovarian cancer
Sharma, A. K., Albahrani, M., Zhang, W., Kufel, C. N., James, S. R., Odunsi, K. O., Klinkebiel, D. L., & Karpf, A. R. (2019) · Epigenetics · doi:10.1080/15592294.2019.1581590 · Cited by 27
Self-citationUncoordinated expression of DNA methylation-related enzymes in human cancer
Liu, J., Cui, X., Jiang, J., Cao, D., He, Y., & Wang, H. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0170-0 · Cited by 13
Epigenetics and Ovarian Cancer
Nephew, K. P., Balch, C., Zhang, S., & Huang, T. H. ‐. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-98094-2_6 · Cited by 11
Cited by
Turner, M. C., Andersen, Z. J., Baccarelli, A., Diver, W. R., Gapstur, S. M., Pope, C. A., Prada, D., Samet, J., Thurston, G., & Cohen, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21632 · Cited by 844
Metadata
- Authors
- Zhang, W., Klinkebiel, D., Barger, C. J., Pandey, S., Guda, C., Miller, A., Akers, S. N., Odunsi, K., & Karpf, A. R.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2020-03-24
- Volume
- 12
- Issue
- 3
- Pages
- 764
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W3012971027
- Cited by
- 277
- References
- 88
- FWCI
- 17.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.